Tempus AI’s moat on its healthcare diagnostics platform ... and analytical platform has also emerged as a pivotal growth vector. While the company is still unprofitable, management has already ...
Whales with a lot of money to spend have taken a noticeably bearish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 21 trades. If we consider the specifics ...
In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...
Analysts expect Tempus AI to post earnings of ($0.14) per share and revenue of $200.46 million for the quarter. Tempus AI Trading Up 0.3 % Shares of NASDAQ:TEM opened at $57.39 on Friday.
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report)’s stock price dropped 4.1% during trading on Monday following insider selling activity. The stock traded as low as $48.08 and last traded at $49.31.
Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing.
Whales with a lot of money to spend have taken a noticeably bullish stance on Tempus AI. Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics ...
Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14 ...
In this article, we are going to take a look at where Tempus AI (NASDAQ:TEM) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets have moved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results